We welcome sponsors for our 2027 symposium
Submit your abstract for consideration
We are open to proposals for:
● long presentations (a 20 minutes talk + 10 minutes of questions and discussion)
● short presentations (a 10 minutes talk + 5 minutes of questions and discussion)
● poster presentations (an opportunity for you to share your knowledge and expertise with the immunogenicity community)
We welcome proposals from people who haven’t spoken at a conference before and we hope that our short presentation option will encourage new speakers to come forward and add their voice to the unique immunogenicity forum that is the EIP symposium.
If you deliver a presentation at the symposium or if your poster is displayed your attendance fees are waived – you can attend the full 4 days and participate in all sessions and activities free of charge.
Please provide your contact details and abstract information via our online form
Deadline for abstract submission: 15th November 2026
18th Open Scientific EIP Symposium on Immunogenicity of Biopharmaceuticals
Lisbon, Portugal
15th — 18th March 2027
Gold sponsors
Silver sponsors
Bronze sponsors
About the European Immunogenicity Platform
The European Immunogenicity Platform acts as a central meeting place for European biopharmaceutical companies and scientific experts active in the area of immunogenicity.
Its mission is to build know-how and expertise in the field of immunogenicity, driven by a close interaction between industry and scientific advisors.
The European Immunogenicity Platform represents companies, institutes and professionals involved in research, development, testing, validation, application, production or marketing of immunogenicity assessment tools, as well as those servicing the biotechnology community.
Its scope is:
- Interaction with authorities regarding immunogenicity guidelines.
- Formulate active recommendations regarding immunogenicity.
- Stimulate research addressing the clinical and non-clinical effects of unwanted immunogenicity.
- Collaboration between academia and pharmaceutical companies.
The European Immunogenicity Platform aims to build a broad knowledge-base related to immunogenicity, and to stimulate interactions and developments in the broad field of immunogenicity.
Through its working-group structure, the EIP can react in a focused way on regulatory and scientific evolutions in the immunogenicity-field. The European Immunogenicity Platform was created early 2007 by experts in the field of immunogenicity.